Growth Metrics

Merck (MRK) Gross Margin Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 434.00
Dec 31, 2025 1,209.00
Sep 30, 2025 525.00
Jun 30, 2025 687.00
Mar 31, 2025 545.00
Dec 31, 2024 1,341.00
Sep 30, 2024 769.00
Jun 30, 2024 568.00
Mar 31, 2024 578.00
Dec 31, 2023 317.00
Sep 30, 2023 681.00
Jun 30, 2023 589.00
Mar 31, 2023 462.00
Dec 31, 2022 491.00
Sep 30, 2022 573.00
Jun 30, 2022 249.00
Mar 31, 2022 -152.00
Dec 31, 2021 566.00
Sep 30, 2021 613.00
Jun 30, 2021 912.00
Mar 31, 2021 826.00
Dec 31, 2020 -825.00
Sep 30, 2020 977.00
Jun 30, 2020 899.00
Mar 31, 2020 1,040.00
Dec 31, 2019 -215.00
Sep 30, 2019 782.00
Jun 30, 2019 1,583.00
Mar 31, 2019 981.00
Dec 31, 2018 1,079.00
Sep 30, 2018 367.00
Jun 30, 2018 626.00
Mar 31, 2018 538.00
Dec 31, 2017 247.00
Sep 30, 2017 398.00
Jun 30, 2017 202.00
Mar 31, 2017 209.00
Dec 31, 2016 -35.00
Sep 30, 2016 384.00
Jun 30, 2016 -109.00
Mar 31, 2016 -331.00
Dec 31, 2015 -98.00
Sep 30, 2015 33.00
Jun 30, 2015 173.00
Mar 31, 2015 780.00
Dec 31, 2014 1,279.00
Sep 30, 2014 -1,636.00
Jun 30, 2014 -2,180.00
Mar 31, 2014 -1,326.00